Joseph Edelman

Last updated

Joseph Edelman
Born1955 (age 68–69)
Alma mater BS, Psychology, 1978, University of California, San Diego
MBA, New York University Stern School of Business, 1988
OccupationHedge fund manager
Known forBiotechnology investments
Edelman Family Foundation
Board member of Brown University (former)
New York Genome Center
Athira Pharma
SpouseSusan "Suzy" Lebovitz-Edelman
Parent Isidore Edelman

Joseph Edelman (born 1955) is an American hedge fund manager who founded Perceptive Advisors, a New York City-based hedge fund specializing in the healthcare sector and biotechnology. [1] He helped take biotech firms public via the use of special-purpose acquisition companies.

Contents

Early life and education

Edelman's father, Isidore Edelman, was a scientist who became a professor emeritus of biochemistry and molecular biophysics at Columbia's College of Physicians and Surgeons. [2] Edelman was the third of four children and grew up in San Francisco. [3] [4] [5]

Edelman graduated magna cum laude with a degree in Psychology from the University of California, San Diego in 1978. [6] [7] Subsequently, he enrolled in graduate studies in pharmacology but left the program upon realizing that he sought a different career path than that of his father. [4]

Drawn to the finance sector, he relocated to New York City, where he obtained his MBA from New York University's Stern School of Business in 1988. [1] [4] To support himself during his studies, he worked in accounting, including his role as assistant comptroller for the Actors' Equity Association. [4]

Career

Edelman began his career in 1987 as a biotechnology analyst at brokerage Wall Street Labe, Simpson & Company before moving to Prudential Securities as senior biotech analyst in 1990. [2] In 1994, Edelman joined Paramount Capital Asset Management, running The Aries Funds until 1998. [5] He joined First New York Securities in February 1999, a proprietary trading firm that allocated $6 million for him to manage an account. [4]

In July 1999, Edelman founded Perceptive Advisors, a hedge fund firm focused on identifying and investing in promising technologies and innovations in the field of biotechnology. [4] [1] The firm began with $6 million in assets and grew to $4.1 billion by 2018. [4] By 2018, its flagship hedge fund, the Perceptive Life Sciences Fund, had delivered annualized gains of 30 percent net of fees since its inception. [4]

Edelman's firm's assets further grew to $8 billion in April 2023 and $10 billion in July that year. [8] [9] In addition to Perceptive Life Sciences, he has invested in small and mid-cap biotech firms such as CymaBay Therapeutics and Cerevel Therapeutics. [8]

Edelman played a significant role in the establishment of ARYA Sciences Acquisition Corp I, II, III, IV, and V. [10] [11] [12] The special purpose acquisition companies (SPACs) were created to facilitate mergers, acquisitions, and public listings for companies in the biotechnology, pharmaceutical, and healthcare industries. [11] In 2022, Perceptive settled charges with the U.S. Securities and Exchange Commission (SEC), accepting a censure and paying a $1.5 million fine. The SEC claimed that the firm had failed to disclose to investors that the firm's employees had stakes in the SPACs the investors were directed to. [13]

Edelman is on the boards of directors at the New York Genome Center, Athira Pharma, and Xontogeny, a support firm for early-stage life science companies. [14] [15] [16] In September 2024, he resigned from the Brown University board of trustees over a planned vote on divestment from Israel. [17] [18]

Edelman Family Foundation

He established the Edelman Family Foundation. [19] According to an investigation by the Huffington Post, the foundation was the primary funder enabling the creation of Do No Harm, an advocacy group that opposes anti-racism education in public schools and gender-affirming care for minors; the donation is characterized by the Foundation in its IRS filing as "to provide support to protect healthcare from a radical, divisive, and discriminatory ideology." [20] [21] [22] Other recipients of Foundation funds include the Cato Institute, the Foundation Against Intolerance and Racism, the Foundation for Individual Rights and Expression, the Manhattan Institute (funds, according to tax filings, intended to support a “gender identity initiative”), Parents Defending Education, PragerU, and unaccredited university UATX. The Foundation stopped providing funding to the Center for Reproductive Rights due to what the Foundation described as the Center's "adoption of gender ideology". [21]

Personal life

He is married to Susan "Suzy" Lebovitz-Edelman, who is co-chair of the Edelman Family Foundation. [21] She was educated at Princeton Day School, and earned a bachelor's degree from Brown University. [23]

In 2021, they bought an 18,000 square foot oceanfront mansion in a gated community in Laguna Beach, California for US$70 million, a record for Orange County. [24]

Related Research Articles

<span class="mw-page-title-main">Vertex Pharmaceuticals</span> American pharmaceutical company

Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in South Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England.

Daniel Seth Loeb is an American investor, hedge fund manager, and philanthropist. He is the founder and chief executive of Third Point, a New York-based hedge fund focused on event-driven, value-oriented investing with $4 billion in assets under management, as of December 2023. New York magazine noted that Loeb's "preferred strategy" is to buy into troubled companies, which "is the key to his success." Regarding his active involvement in the companies in which he invests, Loeb was described as "one of the most successful activists" in 2014.

Khosla Ventures is a private American venture capital firm based in Menlo Park, California. It was founded by entrepreneur Vinod Khosla in 2004. The firm focused on early-stage companies in the Internet, computing, mobile, financial services, agriculture, healthcare and clean technology sectors. Some of its most successful investments include Affirm, DoorDash, Square, Impossible Foods, Instacart, and OpenAI.

John Alfred Paulson is an American billionaire hedge fund manager. He leads Paulson & Co., a New York–based investment management firm he founded in 1994. He has been called "one of the most prominent names in high finance", and "a man who made one of the biggest fortunes in Wall Street history."

<span class="mw-page-title-main">Daniel Och</span> American financier and billionaire

Daniel Och is an American billionaire hedge fund manager, and philanthropist. He is the founder, chairman and former CEO of Och-Ziff Capital Management, a global hedge fund and alternative asset management firm. According to Forbes he has a net worth of US$3.6 billion, as of August 2021.

<span class="mw-page-title-main">Barry Sternlicht</span> American businessman (born 1960)

Barry Stuart Sternlicht is an American billionaire and the co-founder, chairman, and CEO of Starwood Capital Group, an investment fund with over $100 billion in assets under management. He is also chairman of Starwood Property Trust. He is the founder of Starwood Hotels and Resorts Worldwide and served as its Chairman and CEO from 1995 to 2005. As of May 2023, his net worth was estimated at $4.6 billion.

James Tomilson "Tom" Hill III is an American billionaire hedge fund manager, the former president and CEO of Blackstone Alternative Asset Management (BAAM), Blackstone Group's hedge funds business.

Leon G. Cooperman is an American billionaire investor and hedge fund manager. He is the chairman and CEO of Omega Advisors, a New York-based investment advisory firm managing over $3.3 billion in assets under management, the majority consisting of his personal wealth.

Atlas Venture is an early-stage venture capital firm that creates and invests in biotechnology startup companies in the U.S. Atlas is headquartered in Cambridge, Massachusetts, where the majority of its investments are located. Atlas raised its thirteenth fund totaling $450 million in March 2022, after raising its Opportunity Fund II totaling $300 million in September 2021.

Arie S. Belldegrun, FACS, is an Israeli-American urologic oncologist, billionaire businessman and investor.

<span class="mw-page-title-main">Chamath Palihapitiya</span> Sri Lankan-born businessman

Chamath Palihapitiya is a Sri Lankan-born Canadian and American venture capitalist, engineer, SPAC sponsor, founder and CEO of Social Capital. Palihapitiya was an early senior executive at Facebook, working at the company from 2007 to 2011. Following his departure from Facebook, Palihapitiya started The Social+Capital Partnership, through which he invested in several companies, including Yammer and Slack. He is a co-host of a technology podcast, All-In, along with David Sacks, Jason Calacanis, and David Friedberg.

Ligand Pharmaceuticals Incorporated is a biopharmaceutical company located in San Diego, California. Founded in 1987 as Progenix Inc., the company went public in 1992. Initially focused on developing its own drugs, a period of turbulence in the early 2000s culminated in its CEO being ejected by the shareholders and provoked a change in focus to the acquisition of existing drugs and forming partnerships to develop them further.

Saba Capital Management (Saba) is a credit relative value focused hedge fund firm established in 2009. It also has strategies in tail hedge, closed-end funds and SPACs.

Barry S. Rosenstein is an American hedge fund manager and billionaire. He is the founder and managing partner of JANA Partners LLC, an activist hedge fund firm. He made $300 million over the merger of Whole Foods with Amazon in April–July 2017.

<span class="mw-page-title-main">William Rastetter</span> American scientist, entrepreneur and venture capitalist

William H.Rastetter, a scientist, entrepreneur and venture capitalist, is the chair of Neurocrine Biosciences, of Fate Therapeutics, and of Daré Bioscience, Inc. in San Diego, California. He was a founding board member and investor in GRAIL, Inc. in Menlo Park, California, and served for a period as the company's interim CEO (2017) and chair (2017-2018). Rastetter is also a director of Regulus Therapeutics and Iambic Therapeutics. He was a partner in the venture firm Venrock (2006-2013), and a trustee at Caltech (2015-2018). He has served as a director (1998-2016) and as chair of Illumina (2005-2016). He advised SVB Leerink (2014-2019) and currently advises Illumina Ventures.

Gregg S. Hymowitz is an American billionaire who is the chairman, chief executive officer and founder of EnTrust Global, a diversified alternative investment firm. Hymowitz is an activist investor, known for his bold investment strategy. According to Forbes, he has an estimated personal net worth of $1.7 billion as of May 2024.

Remy White Trafelet is an American hedge fund manager and investor. He is the president and CEO of investment firm Trafelet & Company, LLC, and Chairman of Hazeltree Treasury Solutions, a company Trafelet founded in 2011.

Trump Media & Technology Group Corp. (TMTG) is an American media and technology company headquartered in Sarasota, Florida. It is best known as the owner of Truth Social and for being primarily owned by former U.S. president Donald Trump. It also plans to launch a subscription based streaming service called TMTG+. Founded by Andy Litinsky and Wes Moss in 2021, it went public on March 26, 2024, after merging with Digital World Acquisition Corp. (DWAC), a special-purpose acquisition company (SPAC).

<span class="mw-page-title-main">Perceptive Advisors</span> Healthcare investment firm in New York

Perceptive Advisors ("Perceptive") is an American investment firm headquartered in New York City. It is focused on making public and private investments in the healthcare and biotechnology industries.

N. Anthony Coles is an American physician, biotechnology entrepreneur, and pharmaceutical leader. Since 2018, Coles has served as chair of the board of directors for Cerevel Therapeutics.

References

  1. 1 2 3 "Joseph Edelman". Forbes. Retrieved March 6, 2018.
  2. 1 2 Crowe, Portia. "A hedge fund manager you've never heard of made $300 million last year". Business Insider. Archived from the original on August 17, 2018. Retrieved August 17, 2018.
  3. ↑ Pearce, Jeremy (December 2, 2004). "Isidore Edelman, 84, Columbia Scientist Who Led Genome Center, Dies". New York Times .
  4. 1 2 3 4 5 6 7 8 "The 41% Man". Institutional Investor. August 13, 2018. Retrieved March 11, 2024.
  5. 1 2 Vardi, Nathan. "A Sixth Sense For Biotech Has Made Joe Edelman A Hedge Fund Star". Forbes. Retrieved March 11, 2024.
  6. ↑ Roche, Julia La. "This hedge fund crushed the competition in 2015". Business Insider. Retrieved March 11, 2024.
  7. ↑ "UC San Diego Alumnus Joseph Edelman Pledges $400,000 to Help Students Facing Mental Health Challenge". today.ucsd.edu. Retrieved March 11, 2024.
  8. 1 2 "Billionaire Joseph Edelman Snaps Up These 2 Biotech Stocks — Here's Why You Should Follow". Yahoo Finance. April 26, 2023. Retrieved March 13, 2024.
  9. ↑ "OC's Wealthiest 2023: Joseph Edelman". Orange County Business Journal. July 25, 2023. Retrieved March 13, 2024.
  10. ↑ "Joseph Edelman: Positions, Relations and Network - MarketScreener". www.marketscreener.com. Retrieved March 11, 2024.
  11. 1 2 "Cerevel Therapeutics and Arya Sciences Acquisition Corp II Announce Business Combination, Creating a Publicly Listed Leader in Neuroscience Drug Development - Cerevel Therapeutics". www.cerevel.com. July 30, 2020. Retrieved March 11, 2024.
  12. ↑ "Perceptive Keeps SPAC Frenzy Going". Institutional Investor. February 12, 2021. Retrieved March 11, 2024.
  13. ↑ Alpert, Lukas I. (September 6, 2022). "Billionaire Joe Edelman's biotech hedge fund hit with SEC charges for not disclosing SPAC conflicts". Market Watch. Retrieved March 14, 2024.
  14. ↑ "Joseph Edelman". Perceptive Advisors. Retrieved March 11, 2024.
  15. ↑ "Joseph E. Edelman". Corporation | Brown University. Retrieved March 11, 2024.
  16. ↑ "Who We Are - Xontogeny" . Retrieved March 11, 2024.
  17. ↑ "Brown University trustee resigns over divestment vote". The Brown Daily Herald. Retrieved September 9, 2024.
  18. ↑ Edelman, Joseph (September 9, 2024). "Why I Am Resigning as a Brown Trustee". The Wall Street Journal .
  19. ↑ "Edelman Family Foundation". Edelman Family Foundation. Retrieved March 13, 2024.
  20. ↑ Chudy, Emily (October 30, 2023). "Billionaire Joseph Edelman accused of 'quietly financing' America's anti-trans movement". Pink News . Retrieved February 8, 2024.
  21. 1 2 3 "The Billionaire Secretly Funding Anti-Trans Advocacy Across The U.S." HuffPost. October 26, 2023. Retrieved April 1, 2024.
  22. ↑ Russell, John (December 2, 2023). "Conservatives use anti-trans hearing to promote conversion therapy over gender-affirming care". LGBTQ Nation. Retrieved April 1, 2024.
  23. ↑ "Princeton Day School Board of Trustees Welcomes Five New Members". Princeton Online. July 17, 2020. Retrieved April 3, 2024.
  24. ↑ Barrera, Sandra (November 30, 2021). "Laguna Beach mansion breaks Orange County record sale price at $70 million". Mercury News. Retrieved April 3, 2024.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.